Meltec Multi-Epitope-Ligand-Technologies GmbH
Records under this name other than patents Meltec Multi-Epitope-Ligand-Technologies GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Meltec Multi-Epitope-Ligand-Technologies GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,150,173 | Automated determining and measuring device and method Formerly held Term ended Term ended Jul 15, 2019 · From the USPTO record | Term ended | Term ended Jul 15, 2019 | From the USPTO record |
| US 7,676,328 | Method for identifying cell-specific proteins Formerly held Lapsed on the fee record Ended Mar 9, 2014 · From the USPTO record | Lapsed on the fee record | Ended Mar 9, 2014 | From the USPTO record |
| US 6,974,675 | Process for identifying and enriching cell-specific target structures Formerly held Lapsed on the fee record Ended Dec 13, 2013 · From the USPTO record | Lapsed on the fee record | Ended Dec 13, 2013 | From the USPTO record |
| US 6,924,115 | Process for identifying cell-specific target structures Formerly held Lapsed on the fee record Ended Aug 2, 2013 · From the USPTO record | Lapsed on the fee record | Ended Aug 2, 2013 | From the USPTO record |
| US 6,875,579 | Device for binding molecules, molecular groups, molecular parts and/or cells Formerly held Lapsed on the fee record Ended Apr 5, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 5, 2013 | From the USPTO record |
| US 7,382,909 | Method for the automatic analysis of microscope images Formerly held Lapsed on the fee record Ended Jun 3, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jun 3, 2012 | From the USPTO record |
| US 6,649,165 | Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using soluble Fc&ggr;RIII receptors Formerly held Lapsed on the fee record Ended Nov 18, 2007 · From the USPTO record | Lapsed on the fee record | Ended Nov 18, 2007 | From the USPTO record |
| US 6,638,506 | Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using antibodies to Fc&ggr;RIII Formerly held Lapsed on the fee record Ended Oct 28, 2007 · From the USPTO record | Lapsed on the fee record | Ended Oct 28, 2007 | From the USPTO record |
| US 6,638,515 | Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using protein V Formerly held Lapsed on the fee record Ended Oct 28, 2007 · From the USPTO record | Lapsed on the fee record | Ended Oct 28, 2007 | From the USPTO record |